Skip to main content

Fetal Hydrops and Heart Failure

Pediatric Cardiology

Abstract

The recognition of fetal hydrops dates to at least a century ago. This chapter will first review the epidemiology and pathophysiology of fetal hydrops. Given the wide spectrum of causes that lead to fluid imbalances in the fetus, the chapter will focus on the cardiac etiologies which are the most common cause of nonimmune hydrops fetalis, followed by a thorough review of appropriate evaluation including fetal echocardiography to guide the frequency of surveillance and need for treatments based on current guidelines. Echocardiographic findings that establish the diagnosis of hydrops will also be reviewed. Lastly, there will be a discussion of fetal interventions, delivery preparation in fetal hydrops, and findings that are associated with poor outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Ballantyne JW. The diseases and deformities of the foetus. Oliver & Boyd; 1895.

    Google Scholar 

  2. Norton ME, Chauhan SP, Dashe JS, Medicine SfM-F. Society for maternal-fetal medicine (SMFM) clinical guideline# 7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015;212:127–39.

    Article  PubMed  Google Scholar 

  3. Huhta J. Guidelines for the evaluation of heart failure in the fetus with or without hydrops. Pediatr Cardiol. 2004;25:274–86.

    Article  CAS  PubMed  Google Scholar 

  4. Désilets V, Audibert F, Wilson R, Audibert F, Brock J-A, Carroll J, Cartier L, Gagnon A, Johnson J-A, Langlois S. Investigation and management of non-immune fetal hydrops. J Obstet Gynaecol Can. 2013;35:923–36.

    Article  PubMed  Google Scholar 

  5. Mittendorf R, Williams MA. Rho (D) immunoglobulin (RhoGAM): how it came into being. Obstet Gynecol. 1991;77:301–3.

    Article  CAS  PubMed  Google Scholar 

  6. Steurer MA, Peyvandi S, Baer RJ, MacKenzie T, Li BC, Norton ME, Jelliffe-Pawlowski LL, Moon-Grady AJ. Epidemiology of live born infants with nonimmune hydrops fetalis—insights from a population-based dataset. J Pediatr. 2017;187(182–188):e3.

    Google Scholar 

  7. Anandakumar C, Biswas A, Wong Y, Chia D, Annapoorna V, Arulkumaran S, Ratnam S. Management of non-immune hydrops: 8 years’ experience. Ultrasound Obstet Gynecol. 1996;8:196–200.

    Article  CAS  PubMed  Google Scholar 

  8. Santolaya J, Alley D, Jaffe R, Warsof SL. Antenatal classification of hydrops fetalis. Obstet Gynecol. 1992;79:256–9.

    CAS  PubMed  Google Scholar 

  9. McFadden D, Taylor G. Cardiac abnormalities and nonimmune hydrops fetalis: a coincidental, not causal, relationship. Pediatr Pathol. 1989;9:11–7.

    Article  CAS  PubMed  Google Scholar 

  10. Ng ZM, Seet MJ, Erng MN, Buendia F, Chang A, Sriram B. Nonimmune hydrops fetalis in a children’s hospital: a six-year series. Singap Med J. 2013;54:487–90.

    Article  Google Scholar 

  11. Bellini C, Donarini G, Paladini D, Calevo MG, Bellini T, Ramenghi LA, Hennekam RC. Etiology of non-immune hydrops fetalis: an update. Am J Med Genet A. 2015;167:1082–8.

    Article  Google Scholar 

  12. Wieczorek A, Hernandez-Robles J, Ewing L, Leshko J, Luther S, Huhta J. Prediction of outcome of fetal congenital heart disease using a cardiovascular profile score. Ultrasound Obstet Gynecol. 2008;31:284–8.

    Article  CAS  PubMed  Google Scholar 

  13. Bellini C, Hennekam RC. Non-immune hydrops fetalis: a short review of etiology and pathophysiology. Am J Med Genet A. 2012;158:597–605.

    Article  CAS  Google Scholar 

  14. Brace RA. Fluid distribution in the fetus and neonate. In: Fox W, Polin RA, Abam SH, editors. Fetal and neonatal physiology. 3rd ed. Philadelphia: Saunders; 2004. p. 1341–64.

    Chapter  Google Scholar 

  15. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19:312–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Brace RA, Valenzuela GJ. Effects of outflow pressure and vascular volume loading on thoracic duct lymph flow in adult sheep. Am J Phys Regul Integr Comp Phys. 1990;258:R240–4.

    CAS  Google Scholar 

  17. Flessner MF. Distributed model of peritoneal transport: implications of the endothelial glycocalyx. 2008.

    Google Scholar 

  18. Apkon M. Pathophysiology of hydrops fetalis. Semin Perinatol. 1995;19:437–46.

    Article  CAS  PubMed  Google Scholar 

  19. Bellini C, Hennekam RC, Fulcheri E, Rutigliani M, Morcaldi G, Boccardo F, Bonioli E. Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet A. 2009;149A:844–51.

    Article  PubMed  Google Scholar 

  20. Knilans TK. Cardiac abnormalities associated with hydrops fetalis. Semin Perinatol. 1995;19:483–92.

    Article  CAS  PubMed  Google Scholar 

  21. Nimrod C, Keane P, Harder J, Davies D, Kondo C, Takahashi Y, Wong T, Maloney J, Nicholson S. Atrial natriuretic peptide production in association with nonimmune fetal hydrops. Am J Obstet Gynecol. 1988;159:625–8.

    Article  CAS  PubMed  Google Scholar 

  22. Di Lieto A, Pollio F, Catalano D, Gallo F, De Falco M, Minutolo R, Memoli B. Atrial natriuretic factor in amniotic fluid and in maternal venous blood of pregnancies with fetal cardiac malformations and chromosomal abnormalities. J Matern Fetal Neonatal Med. 2002;11:183–7.

    Article  PubMed  Google Scholar 

  23. Silverman NH, Kleinman CS, Rudolph AM, Copel JA, Weinstein EM, Enderlein MA, Golbus M. Fetal atrioventricular valve insufficiency associated with nonimmune hydrops: a two-dimensional echocardiographic and pulsed Doppler ultrasound study. Circulation. 1985;72:825–32.

    Article  CAS  PubMed  Google Scholar 

  24. Isaacs H. Fetal and neonatal cardiac tumors. Pediatr Cardiol. 2004;25:252–73.

    Article  PubMed  Google Scholar 

  25. Yuan S-M. Fetal cardiac tumors: clinical features, management and prognosis. J Perinat Med. 2018;46:115–21.

    Article  PubMed  Google Scholar 

  26. Pedra SR, Smallhorn JF, Ryan G, Chitayat D, Taylor GP, Khan R, Abdolell M, Hornberger LK. Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation. 2002;106:585–91.

    Article  PubMed  Google Scholar 

  27. Ten Cate FEU, Breur JM, Cohen MI, Boramanand N, Kapusta L, Crosson JE, Brenner JI, Lubbers LJ, Friedman AH, Vetter VL. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol. 2001;37:1129–34.

    Article  Google Scholar 

  28. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, Hornberger LK. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol. 2002;40:796–802.

    Article  CAS  PubMed  Google Scholar 

  29. Barron SD, Pass RF. Infectious causes of hydrops fetalis. Semin Perinatol. 1995;19:493–501.

    Article  CAS  PubMed  Google Scholar 

  30. Wagner HR. Cardiac disease in congenital infections. Clin Perinatol. 1981;8:481–97.

    Article  CAS  PubMed  Google Scholar 

  31. Li Y-D, Li Z-A, He Y-H. Premature closure or restriction of the foramen ovale: prenatal diagnosis by directional enhanced flow imaging. J Ultrasound Med. 2013;32:1291–4.

    Article  PubMed  Google Scholar 

  32. Hagen A, Albig M, Schmitz L, Hopp H, Van Baalen A, Becker R, Entezami M. Prenatal diagnosis of isolated foramen ovale obstruction. Fetal Diagn Ther. 2005;20:70–3.

    Article  CAS  PubMed  Google Scholar 

  33. Liu L, He Y-H, Li Z-A, Cui C-Y, Zhang L-z, Li T, Liao S-X, Fan T-B, Peng B-T, Yao H-M. Analysis of etiology, chromosome and prognosis for small left heart system development in 69 fetuses. J Matern Fetal Neonatal Med. 2016;29:493–503.

    Article  PubMed  Google Scholar 

  34. Schall SA, Dalldorf FG. Premature closure of the foramen ovale and hypoplasia of the left heart. Int J Cardiol. 1984;5:103–7.

    Article  CAS  PubMed  Google Scholar 

  35. Maeno YV, Kamenir SA, Sinclair B, van der Velde ME, Smallhorn JF, Hornberger LK. Prenatal features of ductus arteriosus constriction and restrictive foramen ovale in d-transposition of the great arteries. Circulation. 1999;99:1209–14.

    Article  CAS  PubMed  Google Scholar 

  36. Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40:824–9.

    Article  CAS  PubMed  Google Scholar 

  37. Zielinsky P, Busato S. Prenatal effects of maternal consumption of polyphenol-rich foods in late pregnancy upon fetal ductus arteriosus. Birth Defects Res C Embryo Today. 2013;99:256–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kondo T, Kitazawa R, Noda-Maeda N, Kitazawa S. Fetal hydrops associated with spontaneous premature closure of ductus arteriosus. Pathol Int. 2006;56:554–7.

    Article  PubMed  Google Scholar 

  39. Hornberger LK, Sahn DJ. Rhythm abnormalities of the fetus. Heart. 2007;93:1294–300.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Sklansky MS. Fetal cardiac malformations and arrhythmias: detection, diagnosis, management and prognosis. In: Resnik R, Creasy RK, Iams JD, Lockwood CJ, Moore TR, Greene MF, editors. Creasy and Resnik’s maternal-fetal medicine: principles and practice. 8th ed. Elsevier Health Sciences; 2019. p. 348–492.

    Google Scholar 

  41. Zoeller BB. Treatment of fetal supraventricular tachycardia. Curr Treat Options Cardiovasc Med. 2017;19:7.

    Article  PubMed  Google Scholar 

  42. Ishikawa S, Yamada T, Kuwata T, Morikawa M, Yamada T, Matsubara S, Minakami H. Fetal presentation of long QT syndrome – evaluation of prenatal risk factors: a systematic review. Fetal Diagn Ther. 2013;33:1–7.

    Article  PubMed  Google Scholar 

  43. Gyncologists ACoOa. Intrapartum fetal heart rate monitoring: nomenclature, interpretation and general management principles. Obstet Gynecol. 2009;114:192–202.

    Article  Google Scholar 

  44. Glatz AC, Gaynor JW, Rhodes LA, Rychik J, Tanel RE, Vetter VL, Kaltman JR, Nicolson SC, Montenegro L, Shah MJ. Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth. J Thorac Cardiovasc Surg. 2008;136:767–73.

    Article  PubMed  Google Scholar 

  45. Lopes LM, Tavares GM, Damiano AP, Lopes MA, Aiello VD, Schultz R, Zugaib M. Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution. Circulation. 2008;118:1268–75.

    Article  PubMed  Google Scholar 

  46. Zhao H, Cuneo BF, Strasburger JF, Huhta JC, Gotteiner NL, Wakai RT. Electrophysiological characteristics of fetal atrioventricular block. J Am Coll Cardiol. 2008;51:77–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Rodríguez MM, Chaves F, Romaguera RL, Ferrer PL, De la Guardia C, Bruce JH. Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses. Pediatr Dev Pathol. 2002;5:365–74.

    Article  PubMed  Google Scholar 

  48. Lasjaunias P, Hui F, Zerah M, Garcia-Monaco R, Malherbe V, Rodesch G, Tanaka A, Alvarez H. Cerebral arteriovenous malformations in children. Management of 179 consecutive cases and review of the literature. Childs Nerv Syst. 1995;11:66–79; discussion 79

    Article  CAS  PubMed  Google Scholar 

  49. Amer HZ, Heller DS. Chorangioma and related vascular lesions of the placenta – a review. Fetal Pediatr Pathol. 2010;29:199–206.

    Article  PubMed  Google Scholar 

  50. Hedrick HL, Flake AW, Crombleholme TM, Howell LJ, Johnson MP, Wilson RD, Adzick NS. Sacrococcygeal teratoma: prenatal assessment, fetal intervention, and outcome. J Pediatr Surg. 2004;39:430–8.

    Article  PubMed  Google Scholar 

  51. Bryant JH. Case of calcification of the arteries and obliterative endarteritis associated with hydronephrosis in a child aged six months. Guys Hosp Rep. 1901;55:17.

    Google Scholar 

  52. Mastrolia SA, Weintraub AY, Baron J, Sciaky-Tamir Y, Koifman A, Loverro G, Hershkovitz R. Antenatal diagnosis of idiopathic arterial calcification: a systematic review with a report of two cases. Arch Gynecol Obstet. 2015;291:977–86.

    Article  PubMed  Google Scholar 

  53. Sohan K, Carroll SG, Fuente SDL, Soothill P, Kyle P. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand. 2001;80:726–30.

    Article  CAS  PubMed  Google Scholar 

  54. Gimovsky AC, Luzi P, Berghella V. Lysosomal storage disease as an etiology of nonimmune hydrops. Am J Obstet Gynecol. 2015;212:281–90.

    Article  PubMed  Google Scholar 

  55. Society for Maternal-Fetal M, Simpson LL. Twin-twin transfusion syndrome. Am J Obstet Gynecol. 2013;208:3–18.

    Article  Google Scholar 

  56. Bahtiyar MO, Dulay AT, Weeks BP, Friedman AH, Copel JA. Prevalence of congenital heart defects in monochorionic/diamniotic twin gestations: a systematic literature review. J Ultrasound Med. 2007;26:1491–8.

    Article  PubMed  Google Scholar 

  57. Lee H, Bebbington M, Crombleholme TM, North American Fetal Therapy N. The North American fetal therapy network registry data on outcomes of radiofrequency ablation for twin-reversed arterial perfusion sequence. Fetal Diagn Ther. 2013;33:224–9.

    Article  PubMed  Google Scholar 

  58. Weissmann-Brenner A, Ferber A, O’Reilly-Green C, Avila C, Grassi A, Divon MY. Inferior vena cava thrombosis presenting as non-immune hydrops in the fetus of a woman with diabetes. Ultrasound Obstet Gynecol. 2004;23:194–7.

    Article  CAS  PubMed  Google Scholar 

  59. McCoy MC, Katz VL, Gould N, Kuller JA. Non-immune hydrops after 20 weeks’ gestation: review of 10 years’ experience with suggestions for management. Obstet Gynecol. 1995;85:578–82.

    Article  CAS  PubMed  Google Scholar 

  60. Mascaretti RS, Falcao MC, Silva AM, Vaz FA, Leone CR. Characterization of newborns with nonimmune hydrops fetalis admitted to a neonatal intensive care unit. Rev Hosp Clin Fac Med Sao Paulo. 2003;58:125–32.

    Article  PubMed  Google Scholar 

  61. Donofrio M, Moon-Grady A, Hornberger L, Copel J, Sklansky M, Abuhamad A, Cuneo B, Huhta J, Jonas R, Krishnan A, American Heart Association Adults With Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Council on Cardiovascular and Stroke Nursing. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129:2183–242.

    Article  PubMed  Google Scholar 

  62. Laterre M, Bernard P, Vikkula M, Sznajer Y. Improved diagnosis in nonimmune hydrops fetalis using a standardized algorithm. Prenat Diagn. 2018;38:337–43.

    Article  PubMed  Google Scholar 

  63. Picklesimer AH, Oepkes D, Moise KJ Jr, Kush ML, Weiner CP, Harman CR, Baschat AA. Determinants of the middle cerebral artery peak systolic velocity in the human fetus. Am J Obstet Gynecol. 2007;197(526):e1–4.

    Google Scholar 

  64. Zimmerman R, Carpenter RJ Jr, Durig P, Mari G. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. BJOG. 2002;109:746–52.

    PubMed  Google Scholar 

  65. Ismail KM, Martin WL, Ghosh S, Whittle MJ, Kilby MD. Etiology and outcome of hydrops fetalis. J Matern Fetal Med. 2001;10:175–81.

    Article  CAS  PubMed  Google Scholar 

  66. Yinon Y, Chitayat D, Blaser S, Seed M, Amsalem H, Yoo SJ, Jaeggi ET. Fetal cardiac tumors: a single-center experience of 40 cases. Prenat Diagn. 2010;30:941–9.

    Article  PubMed  Google Scholar 

  67. Pruksanusak N, Suntharasaj T, Suwanrath C, Phukaoloun M, Kanjanapradit K. Fetal cardiac rhabdomyoma with hydrops fetalis: report of 2 cases and literature review. J Ultrasound Med. 2012;31:1821–4.

    Article  PubMed  Google Scholar 

  68. Yuan SM. Fetal primary cardiac Tumors during perinatal period. Pediatr Neonatol. 2017;58:205–10.

    Article  PubMed  Google Scholar 

  69. Horikoshi T, Kikuchi A, Matsumoto Y, Tatematsu M, Takae K, Ogiso Y, Nakayama M, Unno N. Fetal hydrops associated with congenital pulmonary myofibroblastic tumor. J Obstet Gynaecol Res. 2005;31:552–5.

    Article  PubMed  Google Scholar 

  70. Sparks TN, Lianoglou BR, Adami RR, Pluym ID, Holliman K, Duffy J, Downum SL, Patel S, Faubel A, Boe NM, Field NT, Murphy A, Laurent LC, Jolley J, Uy C, Slavotinek AM, Devine P, Hodoglugil U, Van Ziffle J, Sanders SJ, MacKenzie TC, Norton ME, University of California Fetal-Maternal C and the University of California SFCfM-FPM. Exome sequencing for prenatal diagnosis in nonimmune hydrops Fetalis. N Engl J Med. 2020;383:1746–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, Cuneo BF, Huhta JC, Jonas RA, Krishnan A, Lacey S, Lee W, Michelfelder EC Sr, Rempel GR, Silverman NH, Spray TL, Strasburger JF, Tworetzky W, Rychik J, American Heart Association Adults With Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Y, Council on Clinical Cardiology CoCS, Anesthesia, Council on C and Stroke N. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129:2183–242.

    Article  PubMed  Google Scholar 

  72. Paladini D, Chita SK, Allan LD. Prenatal measurement of cardiothoracic ratio in evaluation of heart disease. Arch Dis Child. 1990;65:20–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Kleinman C, Nehgme R. Cardiac arrhythmias in the human fetus. Pediatr Cardiol. 2004;25:234–51.

    Article  CAS  PubMed  Google Scholar 

  74. Hsieh YY, Chang FC, Tsai HD, Tsai CH. Longitudinal survey of fetal ventricular ejection and shortening fraction throughout pregnancy. Ultrasound Obstet Gynecol. 2000;16:46–8.

    Article  CAS  PubMed  Google Scholar 

  75. Agata Y, Hiraishi S, Oguchi K, Misawa H, Horiguchi Y, Fujino N, Yashiro K, Shimada N. Changes in left ventricular output from fetal to early neonatal life. J Pediatr. 1991;119:441–5.

    Article  CAS  PubMed  Google Scholar 

  76. Hernandez-Andrade E, Figueroa-Diesel H, Kottman C, Illanes S, Arraztoa J, Acosta-Rojas R, Gratacos E. Gestational-age-adjusted reference values for the modified myocardial performance index for evaluation of fetal left cardiac function. Ultrasound Obstet Gynecol. 2007;29:321–5.

    Article  CAS  PubMed  Google Scholar 

  77. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, Tajik AJ, Seward SB. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr. 1996;9:838–47.

    Article  CAS  PubMed  Google Scholar 

  78. Cruz-Martinez R, Figueras F, Bennasar M, Garcia-Posadas R, Crispi F, Hernandez-Andrade E, Gratacós E. Normal reference ranges from 11 to 41 weeks’ gestation of fetal left modified myocardial performance index by conventional Doppler with the use of stringent criteria for delimitation of the time periods. Fetal Diagn Ther. 2012;32:79–86.

    Article  CAS  PubMed  Google Scholar 

  79. Harada K, Rice MJ, Shiota T, Ishii M, McDonald RW, Reller MD, Sahn DJ. Gestational age-and growth-related alterations in fetal right and left ventricular diastolic filling patterns. Am J Cardiol. 1997;79:173–7.

    Article  CAS  PubMed  Google Scholar 

  80. Gudmundsson S, Huhta JC, Wood DC, Tulzer G, Cohen AW, Weiner S. Venous Doppler ultrasonography in the fetus with nonimmune hydrops. Am J Obstet Gynecol. 1991;164:33–7.

    Article  CAS  PubMed  Google Scholar 

  81. Hofstaetter C, Hofstaetter C, Hansmann M, Eik-Nes SH, Huhta JC, Luther SL. A cardiovascular profile score in the surveillance of fetal hydrops. J Matern Fetal Neonatal Med. 2006;19:407–13.

    Article  PubMed  Google Scholar 

  82. Huhta JC. Right ventricular function in the human fetus. J Perinat Med. 2001;29:381–9.

    Article  CAS  PubMed  Google Scholar 

  83. Maulik D, Yarlagadda P, Youngblood JP, Ciston P. The diagnostic efficacy of the umbilical arterial systolic/diastolic ratio as a screening tool: a prospective blinded study. Am J Obstet Gynecol. 1990;162:1518–23; discussion 1523-5

    Article  CAS  PubMed  Google Scholar 

  84. DeVore GR, Donnerstein RL, Kleinman CS, Platt LD, Hobbins JC. Fetal echocardiography. II. The diagnosis and significance of a pericardial effusion in the fetus using real-time – directed M-mode ultrasound. Am J Obstet Gynecol. 1982;144:693–700.

    Article  CAS  PubMed  Google Scholar 

  85. Romero R. Prenatal diagnosis of congenital anomalies. Norwalk: Appleton & Lange; 1988.

    Google Scholar 

  86. Bryan EM. IgG deficiency in association with placental oedema. Early Hum Dev. 1977;1:133–43.

    Article  CAS  PubMed  Google Scholar 

  87. Ayida GA, Soothill PW, Rodeck CH. Survival in non-immune hydrops fetalis without malformation or chromosomal abnormalities after invasive treatment. Fetal Diagn Ther. 1995;10:101–5.

    Article  CAS  PubMed  Google Scholar 

  88. Hartge DR, Weichert J, Gembicki M, Krapp M. Confirmation of etiology in fetal hydrops by sonographic evaluation of fluid allocation patterns. Eur J Obstet Gynecol Reprod Biol. 2015;195:128–32.

    Article  PubMed  Google Scholar 

  89. McElhinney DB, Tworetzky W, Lock JE. Current status of fetal cardiac intervention. Circulation. 2010;121:1256–63.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Hansmann M, Gembruch U, Bald R, Manz M, Redel DA. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus-a report of 60 cases. Ultrasound Obstet Gynecol. 1991;1:162–8.

    Article  CAS  PubMed  Google Scholar 

  91. Younis JS, Granat M. Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol. 1987;157:1268–9.

    Article  CAS  PubMed  Google Scholar 

  92. Friedman DM, Kim MY, Copel JA, Llanos C, Davis C, Buyon JP. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) study. Am J Cardiol. 2009;103:1102–6.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Lindenburg IT, van Kamp IL, Oepkes D. Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther. 2014;36:263–71.

    Article  PubMed  Google Scholar 

  94. Yinon Y, Grisaru-Granovsky S, Chaddha V, Windrim R, Seaward PG, Kelly EN, Beresovska O, Ryan G. Perinatal outcome following fetal chest shunt insertion for pleural effusion. Ultrasound Obstet Gynecol. 2010;36:58–64.

    Article  CAS  PubMed  Google Scholar 

  95. Jeong BD, Won HS, Lee MY, Shim JY, Lee PR, Kim A. Perinatal outcomes of fetal pleural effusion following thoracoamniotic shunting. Prenat Diagn. 2015;35:1365–70.

    Article  PubMed  Google Scholar 

  96. Kirshon B, Mari G, Moise JK. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Obstet Gynecol. 1990;75:202–5.

    CAS  PubMed  Google Scholar 

  97. Cabrol D, Jannet D, Pannier E. Treatment of symptomatic polyhydramnios with indomethacin. Eur J Obstet Gynecol Reprod Biol. 1996;66:11–5.

    Article  CAS  PubMed  Google Scholar 

  98. Kramer WB, Van den Veyver IB, Kirshon B. Treatment of polyhydramnios with indomethacin. Clin Perinatol. 1994;21:615–30.

    Article  CAS  PubMed  Google Scholar 

  99. Moise KJ Jr. Indomethacin therapy in the treatment of symptomatic polyhydramnios. Clin Obstet Gynecol. 1991;34:310–8.

    Article  PubMed  Google Scholar 

  100. Sago H, Ishii K, Sugibayashi R, Ozawa K, Sumie M, Wada S. Fetoscopic laser photocoagulation for twin-twin transfusion syndrome. J Obstet Gynaecol Res. 2018;44:831–9.

    Article  PubMed  PubMed Central  Google Scholar 

  101. Chalouhi GE, Essaoui M, Stirnemann J, Quibel T, Deloison B, Salomon L, Ville Y. Laser therapy for twin-to-twin transfusion syndrome (TTTS). Prenat Diagn. 2011;31:637–46.

    Article  CAS  PubMed  Google Scholar 

  102. Egawa M, Hayashi S, Yang L, Sakamoto N, Sago H. Chorioamniotic membrane separation after fetoscopic laser surgery for twin-twin transfusion syndrome. Prenat Diagn. 2013;33:89–94.

    Article  PubMed  Google Scholar 

  103. Moodley S, Sanatani S, Potts JE, Sandor GG. Postnatal outcome in patients with fetal tachycardia. Pediatr Cardiol. 2013;34:81–7.

    Article  PubMed  Google Scholar 

  104. Vidaeff AC, Pschirrer ER, Mastrobattista JM, Gilstrap LC 3rd, Ramin SM. Mirror syndrome. A case report. J Reprod Med. 2002;47:770–4.

    PubMed  Google Scholar 

  105. van Selm M, Kanhai HH, Gravenhorst JB. Maternal hydrops syndrome: a review. Obstet Gynecol Surv. 1991;46:785–8.

    Article  PubMed  Google Scholar 

  106. Braun T, Brauer M, Fuchs I, Czernik C, Dudenhausen JW, Henrich W, Sarioglu N. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther. 2010;27:191–203.

    Article  PubMed  Google Scholar 

  107. Wafelman LS, Pollock BH, Kreutzer J, Richards DS, Hutchison AA. Nonimmune hydrops fetalis: fetal and neonatal outcome during 1983-1992. Biol Neonate. 1999;75:73–81.

    Article  CAS  PubMed  Google Scholar 

  108. Cardwell MS. Aspiration of fetal pleural effusions or ascites may improve neonatal resuscitation. South Med J. 1996;89:177–8.

    Article  CAS  PubMed  Google Scholar 

  109. Bence CM, Wagner AJ. Ex utero intrapartum treatment (EXIT) procedures. Semin Pediatr Surg. 2019;28:150820.

    Article  PubMed  Google Scholar 

  110. Randenberg AL. Nonimmune hydrops fetalis part II: does etiology influence mortality? Neonatal Netw. 2010;29:367–80.

    Article  PubMed  Google Scholar 

  111. Czernik C, Proquitte H, Metze B, Buhrer C. Hydrops fetalis – has there been a change in diagnostic spectrum and mortality? J Matern Fetal Neonatal Med. 2011;24:258–63.

    Article  PubMed  Google Scholar 

  112. Abrams ME, Meredith KS, Kinnard P, Clark RH. Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics. 2007;120:84–9.

    Article  PubMed  Google Scholar 

  113. Derderian SC, Jeanty C, Fleck SR, Cheng LS, Peyvandi S, Moon-Grady AJ, Farrell J, Hirose S, Gonzalez J, Keller RL. The many faces of hydrops. J Pediatr Surg. 2015;50:50–4.

    Article  PubMed  Google Scholar 

  114. Nakayama H, Kukita J, Hikino S, Nakano H, Hara T. Long-term outcome of 51 liveborn neonates with non-immune hydrops fetalis. Acta Paediatr. 1999;88:24–8.

    Article  CAS  PubMed  Google Scholar 

  115. Haverkamp F, Noeker M, Gerresheim G, Fahnenstich H. Good prognosis for psychomotor development in survivors with nonimmune hydrops fetalis. BJOG. 2000;107:282–4.

    Article  CAS  PubMed  Google Scholar 

  116. Schwartz SM, Viseskul C, Laxova R, McPherson EW, Gilbert EF. Idiopathic hydrops fetalis report of 4 patients including 2 affected sibs. Am J Med Genet. 1981;8:59–66.

    Article  CAS  PubMed  Google Scholar 

  117. Cumming DC. Recurrent nonimmune hydrops fetalis. Obstet Gynecol. 1979;54:124–6.

    Article  CAS  PubMed  Google Scholar 

  118. Brace RA. Fluid distribution in the fetus and neonate. In: Polin RA, Fox WW, Abam S, editors. Fetal and neonatal physiology. 3rd ed. Elsevier Health Sciences; 2004. p. 1341–64.

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angira Patel .

Editor information

Editors and Affiliations

1 Electronic Supplementary Materials

Fetal echocardiogram sweeping from the thorax into the abdomen, demonstrating Ebstein anomaly with small pericardial effusion and ascites. The septal leaflet (SL) of the tricuspid valve is apically displaced and tethered to the ventricular septum. The inflow portion of the right ventricle appears atrialized (MP4 862 kb)

Fetal echocardiogram with color Doppler demonstrating severe pulmonary insufficiency in a fetus with tetralogy of Fallot with absent pulmonary valve. Note the significant main pulmonary artery (MPA) dilation. RVOT right ventricle outflow tract (MP4 909 kb)

Fetal echocardiogram demonstrating dilated cardiomyopathy with pleural and pericardial effusion. There is poor qualitative biventricular systolic function, and qualitatively large cardiac area compared to total thoracic area. R fetus right, L fetus left, PLE pleural effusion, PCE pericardial effusion (MP4 856 kb)

Fetal echocardiogram of a fetal with restrictive ductus arteriosus, demonstrating a discrete area of narrowing (red arrow) (MP4 655 kb)

Fetal echocardiogram demonstrating pericardial effusion and enlarged cardiac area secondary to complete heart block. Note the atrioventricular dyssynchrony, specifically that the atria contract more frequently than the ventricles (MP4 835 kb)

Fetal echocardiogram of fetus with vein of Galen malformation. There is moderate dilation of the right atrium and ventricle, with moderate tricuspid regurgitation. There is also a small pericardial effusion. R fetus right, L fetus left (MP4 788 kb)

Color Doppler interrogation of the umbilical artery in the acardic fetus of twins with twin reversed arterial perfusion (TRAP) sequence. Note that the umbilical artery flows in a reversed direction, from the placenta (P) toward the acardic fetus (AF) (MP4 664 kb)

Fetal echocardiogram of a fetus with supraventricular tachycardia (SVT) and normal intracardiac anatomy, demonstrating cardiomegaly and pleural effusion. In the setting of chamber dilation or difficult visualization of atrial lateral wall movement, rapid movement of the atrioventricular valves may provide a clue to the presence of SVT (MP4 472 kb)

Fetal echocardiogram of a fetus with idiopathic hydrops fetalis and normal intracardiac anatomy, demonstrating large bilateral pleural effusions. R fetus right, L fetus left (MP4 759 kb)

Fetal echocardiogram of a fetus with idiopathic nonimmune hydrops fetalis at 25 weeks of gestation, demonstrating large bilateral pleural effusion and severe ascites leading to intestinal compression (MP4 5784 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Suh Ro, S., Woo, J., Patel, A. (2023). Fetal Hydrops and Heart Failure. In: Abdulla, Ri., et al. Pediatric Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-42937-9_26-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42937-9_26-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-42937-9

  • Online ISBN: 978-3-030-42937-9

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Fetal Hydrops and Heart Failure
    Published:
    16 May 2024

    DOI: https://doi.org/10.1007/978-3-030-42937-9_26-3

  2. Fetal Hydrops and Heart Failure
    Published:
    26 March 2024

    DOI: https://doi.org/10.1007/978-3-030-42937-9_26-2

  3. Original

    Fetal Hydrops and Heart Failure
    Published:
    08 December 2023

    DOI: https://doi.org/10.1007/978-3-030-42937-9_26-1